IL-1 elevations have been reported within brain lesions from patients with Alzheimer's disease (AD), Multiple Sclerosis (MS), Down's Syndrome and HIV-associated dementia [17,23-25]. This evidence concerns the gene IL1A and myeloid sarcoma.